AVGO Q1 2026 Earnings EPS Falls Modestly Short of Estimates Stock Sees Minor Decline ACB Q1 2026 Earnings EPS Miss Tempers Optimism After Return to Profitability Dyne Therapeutics Q1 2026 Earnings EPS Beat Amid Ongoing Clinical Focus AbbVie ABBV Q1 2026 Earnings Slight EPS Beat Amid Steady Performance Forte Biosciences Q1 2026 Earnings Prerevenue Biotech Misses EPS Estimates Stock Dips on Narrower Loss Miss LCID Q1 2026 Earnings WiderThanExpected Loss Highlights Persistent Cash Burn